Clinical Trial Update: Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

View source ↗

Summary

A completed post-marketing surveillance study to monitor safety in real-world use of Sifrol (pramipexole) in patients with Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sifrol (ropinirole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Status: COMPLETED